Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
BMC Immunol ; 13: 22, 2012 Apr 26.
Artículo en Inglés | MEDLINE | ID: mdl-22537317

RESUMEN

BACKGROUND: DC are among the first antigen presenting cells encountering bacteria at mucosal surfaces, and play an important role in maintenance of regular homeostasis in the intestine. Upon stimulation DC undergo activation and maturation and as initiators of T cell responses they have the capacity to stimulate naïve T cells. However, stimulation of naïve murine DC with B. vulgatus or LPS at low concentration drives DC to a semimature (sm) state with low surface expression of activation-markers and a reduced capacity to activate T-cells. Additionally, semimature DC are nonresponsive to subsequent TLR stimulation in terms of maturation, TNF-α but not IL-6 production. Ligation of CD40 is an important mechanism in enhancing DC maturation, function and capacity to activate T-cells. We investigated whether the DC semimaturation can be overcome by CD40 ligation. RESULTS: Upon CD40 ligation smDC secreted IL-12p40 but not the bioactive heterodimer IL-12p70. Additionally, CD40 ligation of smDC resulted in an increased production of IL-6 but not in an increased expression of CD40. Analysis of the phosphorylation pattern of MAP kinases showed that in smDC the p38 phosphorylation induced by CD40 ligation is inhibited. In contrast, phosphorylation of ERK upon CD40 ligation was independent of the DC maturation state. CONCLUSION: Our data show that the semimature differentiation state of DC can not be overcome by CD40 ligation. We suggest that the inability of CD40 ligation in overcoming DC semimaturation might contribute to the tolerogenic phenotype of semimature DC and at least partially account for maintenance of intestinal immune homeostasis.


Asunto(s)
Bacteroides/inmunología , Antígenos CD40/inmunología , Células Dendríticas/inmunología , Animales , Antígenos Bacterianos/inmunología , Diferenciación Celular/efectos de los fármacos , Diferenciación Celular/inmunología , Células Cultivadas , Citocinas/metabolismo , Imidazoles/farmacología , Activación de Linfocitos/efectos de los fármacos , Sistema de Señalización de MAP Quinasas/efectos de los fármacos , Sistema de Señalización de MAP Quinasas/inmunología , Ratones , Ratones Endogámicos C57BL , Fosforilación Oxidativa/efectos de los fármacos , Piridinas/farmacología , Linfocitos T/inmunología
2.
Cell Physiol Biochem ; 29(3-4): 373-80, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22508045

RESUMEN

Many cancer cells metabolize glucose preferentially via pyruvate to lactate instead to CO(2) and H(2)O (oxidative phosphorylation) even in the presence of oxygen (Warburg effect). Dichloroacetate (DCA) is a drug which is able to shift pyruvate metabolism from lactate to acetyl-CoA (tricarboxylic acid cycle) by indirect activation of pyruvate dehydrogenase (PDH). This can subsequently lead to an increased flow of oxygen in the respiratory chain, associated with enhanced generation of reactive oxygen species (ROS) which may cause apoptosis. In order to investigate if DCA may be suitable for neuroblastoma therapy, it was investigated on three human neuroblastoma cell lines whether DCA can reduce lactate production and enhance oxygen consumption. The data show, that DCA (in the low millimolar range) is able to reduce lactate production, but there was only a slight shift to increased oxygen consumption and almost no effect on cell vitality, proliferation and apoptosis of the three cell lines investigated. Therefore, DCA at low millimolar concentrations seems to be only of minor efficacy for neuroblastoma treatment.


Asunto(s)
Ácido Dicloroacético/farmacología , Ácido Láctico/biosíntesis , Neuroblastoma/metabolismo , Oxígeno/metabolismo , Acetilcoenzima A/metabolismo , Apoptosis , Línea Celular Tumoral , Proliferación Celular , Ciclo del Ácido Cítrico , Medios de Cultivo/metabolismo , Ensayos de Selección de Medicamentos Antitumorales , Activación Enzimática , Humanos , Mitocondrias , Neuroblastoma/tratamiento farmacológico , Neuroblastoma/patología , Fosforilación Oxidativa , Complejo Piruvato Deshidrogenasa/metabolismo , Ácido Pirúvico/metabolismo , Especies Reactivas de Oxígeno/metabolismo
3.
Nat Commun ; 9(1): 3467, 2018 08 27.
Artículo en Inglés | MEDLINE | ID: mdl-30150748

RESUMEN

Many bacteria export effector proteins fulfilling their function in membranes of a eukaryotic host. These effector membrane proteins appear to contain signals for two incompatible bacterial secretion pathways in the same protein: a specific export signal, as well as transmembrane segments that one would expect to mediate targeting to the bacterial inner membrane. Here, we show that the transmembrane segments of effector proteins of type III and type IV secretion systems indeed integrate in the membrane as required in the eukaryotic host, but that their hydrophobicity in most instances is just below the threshold required for mediating targeting to the bacterial inner membrane. Furthermore, we show that binding of type III secretion chaperones to both the effector's chaperone-binding domain and adjacent hydrophobic transmembrane segments also prevents erroneous targeting. These results highlight the evolution of a fine discrimination between targeting pathways that is critical for the virulence of many bacterial pathogens.


Asunto(s)
Proteínas Bacterianas/metabolismo , Sistemas de Secreción Bacterianos/metabolismo , Proteínas de la Membrana/metabolismo , Interacciones Hidrofóbicas e Hidrofílicas , Unión Proteica , Virulencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA